Intracranial Hemangiopericytomas: Recurrence, Metastasis, and Radiotherapy

Abstract

Background Intracranial hemangiopericytomas (HPCs) are characterized by high recurrence rates and extracranial metastases. Radiotherapy provides an adjunct to surgery, but the timing of therapy and the patients most likely to benefit remain unclear.

Methods A retrospective review of 20 patients with HPC treated at the University of Texas Southwestern Medical Center between 1985 and 2014 was conducted. Recurrence and metastasis rates along with overall survival (OS) were characterized based on therapeutic approach and tumor pathology using Kaplan-Meier and Cox regression analyses.

Results The mean age was 45.6 years (range: 19–77). Gross total resection (GTR) was achieved in 13 patients, whereas 5 patients underwent subtotal resection. Median follow-up was 91.5 months (range: 8–357). The 5-, 10-, and 15-year recurrence-free survival (RFS) rates were 61, 41, and 20%, respectively. Six patients developed metastases at an average of 113 months (range: 42–231). OS at last follow-up was 80%. Importantly, immediate postoperative adjuvant radiotherapy (IRT) did not influence RFS compared with surgery alone or OS compared with delayed radiotherapy at the time of recurrence.

Conclusion HPCs have high recurrence rates necessitating close follow-up. Surgery remains an important first step, but the timing of radiotherapy for optimal control and OS remains uncertain.

Keywords

hemangiopericytoma - intracranial - radiotherapy - recurrence - survival

• References

• 1 Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmermann's pericytes. Ann Surg 1942; 116 (01) 26-33
• 2 Begg CF, Garret R. Hemangiopericytoma occurring in the meninges: case report. Cancer 1954; 7 (03) 602-606
• 3 Damodaran O, Robbins P, Knuckey N, Bynevelt M, Wong G, Lee G. Primary intracranial haemangiopericytoma: comparison of survival outcomes and metastatic potential in WHO grade II and III variants. J Clin Neurosci 2014; 21 (08) 1310-1314
• 4 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW. WHO Classification of Tumours of the Central Nervous System. Revised Fo. Lyon, France: World Health Organization; 2016: 408
• 5 Perry A, Scheithauer BW, Nascimento AG. The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges. Am J Surg Pathol 1997; 21 (11) 1354-1360
• 6 Louis DN, Ohgaki H, Wiestler OD. , et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114 (02) 97-109
• 7 Ghia AJ, Chang EL, Allen PK. , et al. Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy. Neurosurgery 2013; 73 (04) 624-630 , discussion 630–631
• 8 Kim JH, Jung H-W, Kim Y-S. , et al. Meningeal hemangiopericytomas: long-term outcome and biological behavior. Surg Neurol 2003; 59 (01) 47-53 , discussion 53–54
• 9 Kim JW, Kim DG, Chung H-T. , et al. Gamma Knife stereotactic radiosurgery for intracranial hemangiopericytomas. J Neurooncol 2010; 99 (01) 115-122
• 10 Olson C, Yen C-P, Schlesinger D, Sheehan J. Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife surgery. J Neurosurg 2010; 112 (01) 133-139
• 11 Rutkowski MJ, Jian BJ, Bloch O. , et al. Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer 2012; 118 (06) 1628-1636
• 12 Schiariti M, Goetz P, El-Maghraby H, Tailor J, Kitchen N. Hemangiopericytoma: long-term outcome revisited. Clinical article. J Neurosurg 2011; 114 (03) 747-755
• 13 Chen LF, Yang Y, Yu XG, Gui QP, Xu BN, Zhou DB. Multimodal treatment and management strategies for intracranial hemangiopericytoma. J Clin Neurosci 2015; 22 (04) 718-725
• 14 Dufour H, Métellus P, Fuentes S. , et al. Meningeal hemangiopericytoma: a retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurgery 2001; 48 (04) 756-762 , discussion 762–763
• 15 Rutkowski MJ, Sughrue ME, Kane AJ. , et al. Predictors of mortality following treatment of intracranial hemangiopericytoma. J Neurosurg 2010; 113 (02) 333-339
• 16 Klinger DR, Flores BC, Lewis JJ. , et al. Atypical Meningiomas: recurrence, reoperation, and radiotherapy. World Neurosurg 2015; 84 (03) 839-845
• 17 Akiyama M, Sakai H, Onoue H, Miyazaki Y, Abe T. Imaging intracranial haemangiopericytomas: study of seven cases. Neuroradiology 2004; 46 (03) 194-197
• 18 Liu G, Chen ZY, Ma L, Lou X, Li SJ, Wang YL. Intracranial hemangiopericytoma: MR imaging findings and diagnostic usefulness of minimum ADC values. J Magn Reson Imaging 2013; 38 (05) 1146-1151
• 19 Righi V, Tugnoli V, Mucci A, Bacci A, Bonora S, Schenetti L. MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma. Oncol Rep 2012; 28 (04) 1461-1467
• 20 Towner JE, Johnson MD, Li YM. Intraventricular hemangiopericytoma: a case report and literature review. World Neurosurg 2016; 89: 728.e5-728.e10
• 21 Sun SQ, Cai C, Murphy RKJ. , et al. Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery 2014; 75 (04) 356-363 , discussion 363
• 22 Robinson DR, Wu YM, Kalyana-Sundaram S. , et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 2013; 45 (02) 180-185